InvestorsHub Logo
Followers 11
Posts 898
Boards Moderated 0
Alias Born 09/10/2019

Re: jav0033 post# 352286

Tuesday, 02/22/2022 8:10:49 PM

Tuesday, February 22, 2022 8:10:49 PM

Post# of 461408
Anavex will go the way of CytoDyn imo. Great drug, no side effects, many potential indications to possibly be treated. In the toilet because of a narcissistic CEO. Not interested in the "details" such has what just happened to the Rett results release, and the sloppy follow up pr's. CYDY's CEO's got axed, but it was too late, too bad because just like Anavex it had great potential. I once was hopeful that 2023 would be the year, but I'm glad I got out in the low 20's. With Missling running the ship, I don't believe it will ever get there again.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News